PL367267A1 - Antineoplastic combinations - Google Patents

Antineoplastic combinations

Info

Publication number: PL367267A1
Authority: PL; Poland
Prior art keywords: antineoplastic combinations; antineoplastic; combinations
Prior art date: 2001-06-01

Application number

PL02367267A

Other languages

Polish (pl)

Inventor

Gary Dukart

James Joseph Gibbons Jr.

Original Assignee

Wyeth

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-01

Filing date

2002-05-29

Publication date

2005-02-21

2002-05-29 Application filed by Wyeth filed Critical Wyeth

2005-02-21 Publication of PL367267A1 publication Critical patent/PL367267A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL02367267A 2001-06-01 2002-05-29 Antineoplastic combinations PL367267A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US29523601P	2001-06-01	2001-06-01
US29519001P	2001-06-01	2001-06-01

Publications (1)

Publication Number	Publication Date
PL367267A1 true PL367267A1 (en)	2005-02-21

Family

ID=26968972

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02367267A PL367267A1 (en)	2001-06-01	2002-05-29	Antineoplastic combinations

Country Status (17)

Country	Link
EP (1)	EP1392286A2 (en)
JP (1)	JP2004532883A (en)
KR (1)	KR100875611B1 (en)
CN (1)	CN100496485C (en)
AU (2)	AU2002259309B2 (en)
BR (1)	BR0210101A (en)
CA (1)	CA2447732A1 (en)
CO (1)	CO5540294A2 (en)
EA (1)	EA007530B1 (en)
HU (1)	HUP0400006A2 (en)
IL (1)	IL158800A0 (en)
MX (1)	MXPA03010907A (en)
NO (1)	NO20035317L (en)
NZ (1)	NZ529877A (en)
PL (1)	PL367267A1 (en)
SG (1)	SG153647A1 (en)
WO (1)	WO2002098416A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ309247B6 (en)	2001-02-19	2022-06-22	Novartis Ag	40-O- (2-hydroxyethyl) rapamycin for use as the sole active ingredient in treating a solid tumour
UA83484C2 (en) *	2003-03-05	2008-07-25	Уайт	Method for treating breast cancer using combination of rapamycin derivative and aromatase inhibitor, pharmaceutical composition
AR046194A1 (en)	2003-11-04	2005-11-30	Mayo Foundation	TREATMENT METHOD OF MANTO CELL LYMPHOMA
AU2006210572B2 (en)	2005-02-03	2011-08-04	The General Hospital Corporation	Method for treating gefitinib resistant cancer
PE20070763A1 (en) *	2005-11-04	2007-08-08	Wyeth Corp	ANTINEOPLASTIC COMBINATIONS OF AN INHIBITOR OF mTOR, TRASTUZUMAB AND / OR HKI-272
CN103446138A (en) *	2005-11-21	2013-12-18	诺瓦提斯公司	Neuroendocrine tumor treatment using mtor inhibitors
GB0523658D0 (en) *	2005-11-21	2005-12-28	Novartis Ag	Organic compounds
US20090023768A1 (en) *	2006-02-24	2009-01-22	Novartis Ag	Rapamycin derivatives for treating neuroblastoma
AU2007240548A1 (en) *	2006-04-05	2007-11-01	Novartis Ag	Combinations of therapeutic agents for treating cancer
PT2481402T (en) *	2007-03-07	2018-10-18	Abraxis Bioscience Llc	Nanoparticle comprising rapamycin and albumin as anticancer agent
US8022216B2 (en)	2007-10-17	2011-09-20	Wyeth Llc	Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
MX365008B (en)	2008-06-17	2019-05-20	Wyeth Llc	Antineoplastic combinations containing hki-272 and vinorelbine.
EP4424375A2 (en)	2008-08-04	2024-09-04	Wyeth LLC	Antineoplastic combinations of neratinib and capecitabine
DK3000467T3 (en)	2009-04-06	2023-03-27	Wyeth Llc	TREATMENT WITH NERATINIB AGAINST BREAST CANCER
CN103721189A (en) *	2013-12-27	2014-04-16	刘玉含	Meningeoma nursing medicine and preparation method thereof
CN105168204A (en) *	2015-09-06	2015-12-23	江志鑫	Pharmaceutical composition containing mitomycin and capable of resisting colon cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5066493A (en) *	1978-11-03	1991-11-19	American Home Products Corporation	Rapamycin in treatment of tumors
US4401653A (en) *	1981-03-09	1983-08-30	Ayerst, Mckenna & Harrison Inc.	Combination of rapamycin and picibanil for the treatment of tumors
EP0525960B1 (en) *	1991-06-18	1996-03-20	American Home Products Corporation	Use of rapamycin for the treatment of adult T-cell leukemia/lymphoma
TWI286074B (en) *	2000-11-15	2007-09-01	Wyeth Corp	Pharmaceutical composition containing CCI-779 as an antineoplastic agent
CZ309247B6 (en) *	2001-02-19	2022-06-22	Novartis Ag	40-O- (2-hydroxyethyl) rapamycin for use as the sole active ingredient in treating a solid tumour

2002
- 2002-05-29 PL PL02367267A patent/PL367267A1/en not_active Application Discontinuation
- 2002-05-29 HU HU0400006A patent/HUP0400006A2/en unknown
- 2002-05-29 BR BR0210101-7A patent/BR0210101A/en not_active Application Discontinuation
- 2002-05-29 SG SG200507698-9A patent/SG153647A1/en unknown
- 2002-05-29 MX MXPA03010907A patent/MXPA03010907A/en not_active Application Discontinuation
- 2002-05-29 EP EP02729310A patent/EP1392286A2/en not_active Ceased
- 2002-05-29 IL IL15880002A patent/IL158800A0/en unknown
- 2002-05-29 EA EA200301319A patent/EA007530B1/en not_active IP Right Cessation
- 2002-05-29 AU AU2002259309A patent/AU2002259309B2/en not_active Ceased
- 2002-05-29 JP JP2003501455A patent/JP2004532883A/en not_active Withdrawn
- 2002-05-29 CA CA002447732A patent/CA2447732A1/en not_active Abandoned
- 2002-05-29 KR KR1020037015721A patent/KR100875611B1/en not_active IP Right Cessation
- 2002-05-29 CN CNB02811048XA patent/CN100496485C/en not_active Expired - Fee Related
- 2002-05-29 NZ NZ529877A patent/NZ529877A/en unknown
- 2002-05-29 WO PCT/US2002/016737 patent/WO2002098416A2/en active Application Filing
2003
- 2003-11-26 CO CO03104435A patent/CO5540294A2/en not_active Application Discontinuation
- 2003-11-28 NO NO20035317A patent/NO20035317L/en not_active Application Discontinuation
2008
- 2008-06-18 AU AU2008202690A patent/AU2008202690A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2002098416A3 (en)	2003-03-13
NZ529877A (en)	2006-08-31
SG153647A1 (en)	2009-07-29
HUP0400006A2 (en)	2004-04-28
EA007530B1 (en)	2006-10-27
CN1646120A (en)	2005-07-27
WO2002098416A2 (en)	2002-12-12
KR100875611B1 (en)	2008-12-24
CA2447732A1 (en)	2002-12-12
CN100496485C (en)	2009-06-10
AU2008202690A1 (en)	2008-07-10
EA200301319A1 (en)	2004-04-29
IL158800A0 (en)	2004-05-12
NO20035317L (en)	2003-12-22
CO5540294A2 (en)	2005-07-29
BR0210101A (en)	2004-06-08
KR20040025923A (en)	2004-03-26
EP1392286A2 (en)	2004-03-03
JP2004532883A (en)	2004-10-28
AU2002259309B2 (en)	2008-05-01
NO20035317D0 (en)	2003-11-28
MXPA03010907A (en)	2004-02-17

Publication	Publication Date	Title
IL159859A0 (en)	2004-06-20	Antineoplastic combinations
IL160851A0 (en)	2004-08-31	Thiopene-and thiazolesulfonamides as antineoplastic agents
ZA200603888B (en)	2007-05-30	Antineoplastic combinations
IL158800A0 (en)	2004-05-12	Antineoplastic combinations
DE60233129D1 (en)	2009-09-10	Rotorsystemschwingungsdämpfer
DE60223825D1 (en)	2008-01-10	Ethynylierungsverfahren
GB0105113D0 (en)	2001-04-18	Punchbag
AU2002313943A8 (en)	2008-01-03	Electromobile
EP1355643A4 (en)	2004-11-17	Epoxyvibsanin b
GB0125662D0 (en)	2001-12-19	Formultion
GB0112858D0 (en)	2001-07-18	Matchit
GB0112053D0 (en)	2001-07-11	Bacsac
GB0110100D0 (en)	2001-06-20	Autoselect
GB0116510D0 (en)	2001-08-29	Barit
GB0106578D0 (en)	2001-05-09	SugarPlay/TVXTalk
GB0107688D0 (en)	2001-05-16	Plasicab
GB0109840D0 (en)	2001-06-13	Bedpouch
GB0105454D0 (en)	2001-04-25	Eye-trek-2001 multimedia-helmet visualiser
GB0110942D0 (en)	2001-06-27	Vita-tea
GB0111506D0 (en)	2001-07-04	Gillbox
GB0100986D0 (en)	2001-02-28	Back-saver
GB0112285D0 (en)	2001-07-11	Topix
GB0106128D0 (en)	2001-05-02	Easiknees
GB0113029D0 (en)	2001-07-18	Storet
GB0114387D0 (en)	2001-08-08	Osteodistraction

Legal Events

Date	Code	Title	Description
2010-12-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)